Alzheimer’s Disease A Physician’s Guide to Practical Management
Ralph W. Richter
Alzheimer’s Disease A Physician’s Guide to Practical Management Current Clinical Neurology - illustrated, reprint - New York Springer Science & Business Media 2003 - 479 pages
Alzheimer’s disease (AD) is a devastating and dehumanizing illness affecting increasingly large numbers of elderly and even middle-aged persons in a worldwide epidemic. Alzheimer’s Disease: A Physician’s Guide to Practical Management was written by selected clinicians and scientists who represent some of the world’s leading centers of excellence in AD research. The editors are proud and grateful for their profound contributions. This book is particularly designed to assist physicians and other health-care professionals in the evaluation, assessment, and treatment of individuals with AD. At the same time, by illuminating the basic scientific background, we hope to provide state-of-the art information about the disease and possible future therapeutic strategies. The recent psychiatric treatment aspects of AD are also clearly presented. Because the early diagnosis of the dementia process is now considered of increasing importance, we focus particularly in several chapters on early changes and preclinical conditions, such as mild cognitive impairment and predementia AD.
1592596614 9781592596614 = abnormalities activity ADAScog Alzheimer disease Alzheimer’s disease AMPA AMPA receptor amyloid amyloid precursor protein apathy apolipoprotein Arch Neurol assessment associated behavioral brain caregiver cerebral changes cholinergic Clin clinical trials clinician cognitive function cortex deficits demented patients depression diagnosis differences differentiation disorders donepezil dose doubleblind drugs dysfunction effects efficacy elderly estrogen etal frontal frontotemporal dementia galantamine gene genetic Geriatr Psychiatry global growth factor hippocampal hNSC increased inhibitors inthe lesions levels Lewy bodies longterm markers measures memantine memory metabolism mice mild cognitive impairment MMSE mutations neurodegenerative neurofibrillary neurofibrillary tangles Neurology neurons neuroprotective neuropsychiatric symptoms neuropsychological Neurosci odor ofthe olfactory oxidative stress Parkinson’s disease pathology patients with Alzheimer’s placebo placebocontrolled plaques potential precursor protein predementia presenilin progressive receptor risk factors rivastigmine Scale score significant stem cells syndrome tacrine tau protein testosterone therapeutic therapy treatment vascular dementia
--Alzheimer Disease. --Medical › Neurology --Medical / Clinical Medicine --Medical / Neurology
WT 155 A4756 2004 RC523.A3748 2004
616.8’31 RIC
Alzheimer’s Disease A Physician’s Guide to Practical Management Current Clinical Neurology - illustrated, reprint - New York Springer Science & Business Media 2003 - 479 pages
Alzheimer’s disease (AD) is a devastating and dehumanizing illness affecting increasingly large numbers of elderly and even middle-aged persons in a worldwide epidemic. Alzheimer’s Disease: A Physician’s Guide to Practical Management was written by selected clinicians and scientists who represent some of the world’s leading centers of excellence in AD research. The editors are proud and grateful for their profound contributions. This book is particularly designed to assist physicians and other health-care professionals in the evaluation, assessment, and treatment of individuals with AD. At the same time, by illuminating the basic scientific background, we hope to provide state-of-the art information about the disease and possible future therapeutic strategies. The recent psychiatric treatment aspects of AD are also clearly presented. Because the early diagnosis of the dementia process is now considered of increasing importance, we focus particularly in several chapters on early changes and preclinical conditions, such as mild cognitive impairment and predementia AD.
1592596614 9781592596614 = abnormalities activity ADAScog Alzheimer disease Alzheimer’s disease AMPA AMPA receptor amyloid amyloid precursor protein apathy apolipoprotein Arch Neurol assessment associated behavioral brain caregiver cerebral changes cholinergic Clin clinical trials clinician cognitive function cortex deficits demented patients depression diagnosis differences differentiation disorders donepezil dose doubleblind drugs dysfunction effects efficacy elderly estrogen etal frontal frontotemporal dementia galantamine gene genetic Geriatr Psychiatry global growth factor hippocampal hNSC increased inhibitors inthe lesions levels Lewy bodies longterm markers measures memantine memory metabolism mice mild cognitive impairment MMSE mutations neurodegenerative neurofibrillary neurofibrillary tangles Neurology neurons neuroprotective neuropsychiatric symptoms neuropsychological Neurosci odor ofthe olfactory oxidative stress Parkinson’s disease pathology patients with Alzheimer’s placebo placebocontrolled plaques potential precursor protein predementia presenilin progressive receptor risk factors rivastigmine Scale score significant stem cells syndrome tacrine tau protein testosterone therapeutic therapy treatment vascular dementia
--Alzheimer Disease. --Medical › Neurology --Medical / Clinical Medicine --Medical / Neurology
WT 155 A4756 2004 RC523.A3748 2004
616.8’31 RIC